APNAR PHARMA LP FDA Approval ANDA 074823

ANDA 074823

APNAR PHARMA LP

FDA Drug Application

Application #074823

Documents

Review1998-03-30

Application Sponsors

ANDA 074823APNAR PHARMA LP

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001CAPSULE;ORALEQ 1MG BASE0TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDE
002CAPSULE;ORALEQ 2MG BASE0TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDE
003CAPSULE;ORALEQ 5MG BASE0TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDE
004CAPSULE;ORALEQ 10MG BASE0TERAZOSIN HYDROCHLORIDETERAZOSIN HYDROCHLORIDE

FDA Submissions

ORIG1AP1998-03-30
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1999-09-07
LABELING; LabelingSUPPL3AP1999-09-07
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1999-06-18
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2000-06-28
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2001-06-07
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-11-06
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2002-04-19
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-03-05
LABELING; LabelingSUPPL11AP2002-10-01
LABELING; LabelingSUPPL15AP2007-08-09

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

APNAR PHARMA LP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 74823
            [companyName] => APNAR PHARMA LP
            [docInserts] => ["",""]
            [products] => [{"drugName":"TERAZOSIN HYDROCHLORIDE","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 1MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TERAZOSIN HYDROCHLORIDE","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 2MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"},{"drugName":"TERAZOSIN HYDROCHLORIDE","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TERAZOSIN HYDROCHLORIDE","activeIngredients":"TERAZOSIN HYDROCHLORIDE","strength":"EQ 10MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TERAZOSIN HYDROCHLORIDE","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 1MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TERAZOSIN HYDROCHLORIDE","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 2MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TERAZOSIN HYDROCHLORIDE","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 5MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TERAZOSIN HYDROCHLORIDE","submission":"TERAZOSIN HYDROCHLORIDE","actionType":"EQ 10MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.